Is BIOLASE, Inc. (BIOL) a Buy, Sell, or Hold?
NASDAQ : BIOL
BIOLASE, Inc.
$0.02 USD
$0.0 (27.39%)
- Volume
- 2.67M
- Average Volume
- 212.69K
- Market Capitalization
- $731.94K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.94
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.26
| Source | Headline |
|---|---|
|
MegaGen and BIOLASE Invest Nearly $1 Million to Expand Manufacturing Infrastructure at Corona, California Facility
Investment supports expanded production capacity, cleanroom construction, fiber and laser room upgrades, and long-term supply stability for Waterlase and Epic dental laser technologies. Investment Purpose Facility Focus Market Model Core Message Nearly $1 million dollar Corona construction project investment summary Increase manufacturing capacity, quality systems support and supply stability Laser room, fiber room, cleanroom, warehouse, product/material flow and employee spaces MegaGen-led global sales expansion; MegaGen America-led U.S. support Long-term commitment to innovation, quality continuity and clinical laser adoption FOOTHILL RANCH, Calif. prnewswire.com - 2026-06-25 08:00:00 |
